Yeast-produced RBD-based recombinant protein vaccines elicit broadly neutralizing antibodies and durable protective immunity against SARS-CoV-2 infection.
- Resource Type
- Article
- Source
- Cell Discovery; 8/18/2021, Vol. 7 Issue 1, p1-16, 16p
- Subject
RECOMBINANT proteins SARS-CoV-2 YEAST DIMERIC ions IMMUNIZATION VACCINE effectiveness - Language
- ISSN
- 20565968